NASDAQ Basic Materials Chemicals - Specialty ZY

Zymergen Inc.

$ 2.43 0.00 %

Zymergen Inc. specializes in the creation, advancement, and market introduction of various biological entities and substances, including microorganisms, specialized molecules, and novel materials. The company provides an advanced automation platform, which incorporates adaptable automation carts—modular hardware components enabling the construction of laboratory work cells tailored to specific research requirements. Additionally, it features cloud-based automation control software designed to manage integrated automated systems efficiently. Zymergen's diverse clientele spans sectors such as electronics, packaging, healthcare, agriculture, and others. Established in 2013, Zymergen Inc. is headquartered in Emeryville, California. Since October 19, 2022, the company has operated as a subsidiary under Ginkgo Bioworks Holdings, Inc.

CEO: Joshua J. Hoffmann - https://www.zymergen.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

Hold

DCF

$ -

Loading data...

ZY vs S&P500

Loading data...

No data available.

Quick ratio

5.46

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-0.67

may indicate that the company is undervalued or has poor growth prospects.

EPS

-3.61

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

215.83 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

-70.42 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

-

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.11

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

-4.52

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
N/A
Altman score
N/A
Loading data...

No data available.

Cash / Debt

Cash Ratio
5.25 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.08 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.